Tisotumab Vedotin for Patients With Cervical Cancer
Comprehensive insights on the journey of a patient with cervical cancer and treatment options upon progression, with a focus on tisotumab vedotin.
EP: 1.Overview of Cervical Cancer
EP: 2.Cervical Cancer: The Patient Journey
EP: 3.Patient Perceptions of Cervical Cancer Screening
EP: 4.Treatment Options for Patients With Primary or Recurrent Cervical Cancer
EP: 5.Treatments for Patients With Newly Diagnosed Metastatic Cervical Cancer
EP: 6.Individualized Treatment Selection in Cervical Cancer
EP: 7.Tisotumab Vedotin for Patients With Cervical Cancer
EP: 8.Unmet Needs in the Cervical Cancer Treatment Landscape
EP: 9.Shared Decision-Making in Cervical Cancer
EP: 10.Cervical Cancer: Advocating for Yourself and Communicating With Family
EP: 11.Cervical Cancer: Insight into the Patient Experience
EP: 12.Myths Around Cervical Cancer
Patients With Cervical Cancer Survivor Can Thrive With Social Support
January 31st 2024“When you have support, you have answers to some of your unknowns and that can provide stability and ease in anxiety and depression, and truly propel you into thriving,” a cervical cancer survivor and advocate tells CURE®.
Read More
Fertility Research ‘Long Overdue’ for Patients With Cervical Cancer
November 30th 2023Cervical cancer survivor Kate Weissman talks recent research on follow-up visits for patients after fertility-sparing surgery, and explains why it’s ‘something that the cervical cancer community is owed.’
Listen
Tivdak Confers 30% Reduction in Mortality Risk in Cervical Cancer
October 22nd 2023A 30% reduction in the risk of death versus. investigator’s choice of chemotherapy as second or third line therapy was concluded when Tivdak was combined for the treatment of recurrent or metastatic cervical cancer with disease progression on doublet chemotherapy.
Read More
